This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
AstraZeneca (AZN) - Announces yet another FDA disclosure, this time the grainting of a priority review after the acceptance of regulatory submission for its lymphoma drug Acalabrutinib.
BAE Systems (BA.) - The defence manufacturer beats H1 earnings forecasts after an 11% increase in EBITDA and a 4% increase in sales on a constant currency basis, with the company reiterating its FY targets.
Rio Tinto (RIO) - The dual-listed miner announces $3bn of cash returns for shareholders in the form of a 110c interim dividend and a $1bn share buy back scheme after almost doubling H1 underlying earnings to $3.9bn while reducing pretax costs by $2.1bn.
Royal Mail (RMG) - Could face a class-action lawsuit from sub-postmasters who claim that faulty IT systems resulted in up to 500 false accusations of theft and fraud.
(Sources: Company Newswires, Bloomberg, FT, Reuters)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| BP | BP. | 2.8% | 3.9% | 1.6% |
| British American Tobacco | BATS | 2.4% | 2.5% | -1.1% |
| Centrica | CNA | 2.4% | 4.0% | 1.0% |
| Rolls-Royce | RR. | 10.1% | 11.8% | 3.0% |
| Taylor Wimpey | TW. | 1.4% | 2.9% | 0.6% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research